,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-06-20 05:30:00,"Chicago, IL - June 20, 2017 - Stocks in this week's article include Etsy, Inc. (NASDAQ: ETSY - Free Report ), Live Nation Entertainment, Inc. (NYSE: LYV - Free Report ), Salesforce.com, Inc. (NYSE: CRM - Free Report ), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX - Free Report ) and NeoGenomics, Inc. (NASDAQ: NEO - Free Report ).",0.023671958595514297,0.020522627979516983,0.9558054208755493,neutral,0.0031493306159973145
1,2017-06-20 05:30:00,"Screen of the Week of Zacks Investment Research:

5 Toxic Stocks to Discard or Play Short for Profit

One of the important keys to successful investing is the proper identification of overpriced stocks and correctly priced ones.",0.2405080795288086,0.008766395971179008,0.750725507736206,neutral,0.23174168169498444
2,2017-06-20 05:30:00,"However, in reality, the overpriced toxic stocks and the fairly priced stocks are intermingled in the market place in such a way that it becomes extremely difficult to distinguish them.",0.028426555916666985,0.1927797496318817,0.7787936925888062,neutral,-0.16435319185256958
3,2017-06-20 05:30:00,Investors who can figure out the toxic stocks and abandon them at the right time are likely to gain.,0.5810564756393433,0.08247625827789307,0.3364672064781189,positive,0.4985802173614502
4,2017-06-20 05:30:00,"Generally, toxic stocks are susceptible to external shocks and are loaded with huge debts.",0.044029850512742996,0.23742495477199554,0.718545138835907,neutral,-0.19339510798454285
5,2017-06-20 05:30:00,"Also, sometimes, the price of the toxic stocks is unjustifiably inflated.",0.06517556309700012,0.5643043518066406,0.37052008509635925,negative,-0.4991287887096405
6,2017-06-20 05:30:00,The irrationally high price of the toxic stocks is only temporary as the intrinsic value of these stocks is lower than the current bloated price.,0.02460981346666813,0.8938872218132019,0.08150285482406616,negative,-0.8692774176597595
7,2017-06-20 05:30:00,The inflated price of the toxic stocks can be due to either an irrational exuberance associated with them or some serious fundamental drawback.,0.030512118712067604,0.500529944896698,0.46895796060562134,negative,-0.47001782059669495
8,2017-06-20 05:30:00,"If you own such stocks for a very long period of time, you are sure to see huge erosion in your wealth.",0.03326597809791565,0.8577721118927002,0.10896189510822296,negative,-0.8245061635971069
9,2017-06-20 05:30:00,"On the other hand, if you can pinpoint the toxic stocks accurately, you may gain by resorting to an investing strategy called short selling.",0.20212168991565704,0.01440728921443224,0.7834710478782654,neutral,0.18771439790725708
10,2017-06-20 05:30:00,This strategy allows you to sell a stock first and then buy it when the price falls.,0.028492551296949387,0.0071497210301458836,0.9643576741218567,neutral,0.02134283073246479
11,2017-06-20 05:30:00,"While short selling excels in bear markets, it typically loses money in bull markets.",0.0723898857831955,0.4307730793952942,0.4968370795249939,neutral,-0.3583831787109375
12,2017-06-20 05:30:00,"So, identifying toxic stocks and throwing them away at the right time is the key to protect your portfolio from big losses or make profits by short selling them.",0.09357531368732452,0.027475299313664436,0.8789493441581726,neutral,0.06610001623630524
13,2017-06-20 05:30:00,"Here is a winning strategy that will help you to identify overpriced toxic stocks:

Most recent Debt/Equity Ratio greater than the median industry average : High debt/equity ratio implies high leverage.",0.5066813230514526,0.01784672774374485,0.4754719138145447,positive,0.48883458971977234
14,2017-06-20 05:30:00,High leverage indicates a huge level of repayment that the company has to make in connection with the debt amount.,0.12934015691280365,0.012604632414877415,0.8580551743507385,neutral,0.11673552542924881
15,2017-06-20 05:30:00,P/E using 12-month forward EPS estimate greater than 50 : A very high forward P/E implies that a stock is highly overvalued.,0.27337369322776794,0.15099157392978668,0.5756346583366394,neutral,0.12238211929798126
16,2017-06-20 05:30:00,% Change in F (1) and F (2) Estimate (12 Weeks) less than -5 : Negative EPS estimate revision for this and the next fiscal year during the past 12 weeks points to analysts' pessimism.,0.02289821207523346,0.9613451361656189,0.015756601467728615,negative,-0.9384469389915466
17,2017-06-20 05:30:00,Zacks Rank more than or equal to #3 (Hold) : We have not considered Buy-rated stocks that generally outperform the market.,0.06852714717388153,0.08168552070856094,0.8497873544692993,neutral,-0.013158373534679413
18,2017-06-20 05:30:00,"Here are five of the 19 toxic stocks that showed up on the screen:

Etsy, Inc. (NASDAQ: ETSY - Free Report ) is a Brooklyn, NY-based Internet services company.",0.015872269868850708,0.11906199902296066,0.8650656938552856,neutral,-0.10318972915410995
19,2017-06-20 05:30:00,"It operates a marketplace to make, sell and buy goods online and offline worldwide.",0.043769121170043945,0.004551163874566555,0.9516796469688416,neutral,0.039217956364154816
20,2017-06-20 05:30:00,"Over the last 30 days, its quarter estimates widened from a loss of a penny per share to a loss of 2 cents.",0.057902950793504715,0.9222128987312317,0.019884170964360237,negative,-0.8643099665641785
21,2017-06-20 05:30:00,The company has a Zacks Rank #3.,0.3151754140853882,0.021197421476244926,0.6636272072792053,neutral,0.2939780056476593
22,2017-06-20 05:30:00,You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .,0.05316152796149254,0.01201231312006712,0.934826135635376,neutral,0.041149213910102844
23,2017-06-20 05:30:00,"Live Nation Entertainment, Inc. (NYSE: LYV - Free Report ) is a Beverly Hills, CA-based live entertainment company.",0.02815849706530571,0.005827184300869703,0.9660143852233887,neutral,0.02233131229877472
24,2017-06-20 05:30:00,"Over the past 30 days, its second-quarter 2017 estimates remained unchanged at 17 cents a share.",0.12495975196361542,0.5679605603218079,0.3070797324180603,negative,-0.44300079345703125
25,2017-06-20 05:30:00,The stock currently has a Zacks Rank #3.,0.1364876627922058,0.011149837635457516,0.8523624539375305,neutral,0.12533782422542572
26,2017-06-20 05:30:00,"Salesforce.com, Inc. (NYSE: CRM - Free Report ) is a San Francisco, CA-based computer software industry firm.",0.02408849634230137,0.00647545512765646,0.9694361090660095,neutral,0.017613042145967484
27,2017-06-20 05:30:00,"Over the past one month period, its second quarter earnings estimate has declined 18.2% to 9 cents a share.",0.018884040415287018,0.9719575643539429,0.009158406406641006,negative,-0.9530735015869141
28,2017-06-20 05:30:00,"Currently, the company carries a Zacks Rank #3.",0.078742116689682,0.010858613066375256,0.9103992581367493,neutral,0.06788350641727448
29,2017-06-20 05:30:00,"Boston, MA-based, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX - Free Report ) is a biotechnology company.",0.022243216633796692,0.005451129283756018,0.9723056554794312,neutral,0.016792086884379387
30,2017-06-20 05:30:00,"Over the past one-month period, current quarter estimates remained unchanged at 5 cents per share.",0.16656842827796936,0.34164369106292725,0.4917878806591034,neutral,-0.17507526278495789
31,2017-06-20 05:30:00,The stock currently has a Zacks Rank #3.,0.1364876627922058,0.011149837635457516,0.8523624539375305,neutral,0.12533782422542572
32,2017-06-20 05:30:00,"NeoGenomics, Inc. (NASDAQ: NEO - Free Report ) is a Fort Myers, FL-based company belonging to the biomedical and genetics industry.",0.03023255430161953,0.005038163159042597,0.9647293090820312,neutral,0.02519439160823822
33,2017-06-20 05:30:00,"Over the past one-month period, current quarter estimates remained unchanged at 2 cents per share.",0.1665237545967102,0.3614615797996521,0.4720146358013153,neutral,-0.1949378252029419
34,2017-06-20 05:30:00,The stock currently has a Zacks Rank #3.,0.1364876627922058,0.011149837635457516,0.8523624539375305,neutral,0.12533782422542572
35,2017-06-20 05:30:00,Get the rest of the stocks on the list and start putting this and other ideas to the test.,0.08288666605949402,0.008611055091023445,0.9085022211074829,neutral,0.07427561283111572
36,2017-06-20 05:30:00,It can all be done with the Research Wizard stock picking and backtesting software.,0.02909490093588829,0.007561055943369865,0.9633440375328064,neutral,0.021533844992518425
37,2017-06-20 05:30:00,The Research Wizard is a great place to begin.,0.20742648839950562,0.009130500257015228,0.783443033695221,neutral,0.1982959806919098
38,2017-06-20 05:30:00,It's easy to use.,0.1274539977312088,0.007995017804205418,0.8645509481430054,neutral,0.11945898085832596
39,2017-06-20 05:30:00,Everything is in plain language.,0.028300747275352478,0.02068278007209301,0.9510164260864258,neutral,0.007617967203259468
40,2017-06-20 05:30:00,And it's very intuitive.,0.25123029947280884,0.011599363759160042,0.7371703386306763,neutral,0.23963093757629395
41,2017-06-20 05:30:00,Start your Research Wizard trial today.,0.044511113315820694,0.007261833641678095,0.948227047920227,neutral,0.03724927827715874
42,2017-06-20 05:30:00,"And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.",0.04027906060218811,0.018189366906881332,0.9415315985679626,neutral,0.022089693695306778
43,2017-06-20 05:30:00,Click here to sign up for a free trial to the Research Wizard today .,0.0566948726773262,0.022216657176613808,0.9210885167121887,neutral,0.034478217363357544
44,2017-06-20 05:30:00,"Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.",0.011023171246051788,0.019849004223942757,0.969127893447876,neutral,-0.008825832977890968
45,2017-06-20 05:30:00,An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.,0.011446081101894379,0.010415039025247097,0.9781388640403748,neutral,0.0010310420766472816
46,2017-06-20 05:30:00,Disclosure: Performance information for Zacks' portfolios and strategies are available at:https://www.zacks.com/performance.,0.01448096428066492,0.00816013291478157,0.9773589372634888,neutral,0.00632083136588335
47,2017-06-20 05:30:00,"Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares.",0.043785810470581055,0.011856164783239365,0.9443580508232117,neutral,0.03192964568734169
48,2017-06-20 05:30:00,A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector.,0.8554665446281433,0.022795524448156357,0.1217380091547966,positive,0.832671046257019
49,2017-06-20 05:30:00,"Download it free »

Sign up now for your free trial today and start picking better stocks immediately.",0.25327056646347046,0.01330951601266861,0.7334199547767639,neutral,0.23996105790138245
50,2017-06-20 05:30:00,"And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets.",0.7471936345100403,0.01405523344874382,0.23875106871128082,positive,0.733138382434845
51,2017-06-20 05:30:00,Don't wait for the market to get better before you decide to do better.,0.32742658257484436,0.027078744024038315,0.6454946994781494,neutral,0.30034783482551575
52,2017-06-20 05:30:00,"Start learning how to be a better trader today: https://at.zacks.com/?id=111

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.",0.011164776980876923,0.025693578645586967,0.9631416201591492,neutral,-0.014528801664710045
53,2017-06-20 05:30:00,An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.,0.011446081101894379,0.010415039025247097,0.9781388640403748,neutral,0.0010310420766472816
54,2017-06-20 05:30:00,"About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the ""#1 site for screening stocks"" by Money Magazine.",0.8801765441894531,0.015994274988770485,0.10382916778326035,positive,0.8641822934150696
55,2017-06-20 05:30:00,But powerful screening tools is just the start.,0.09495247155427933,0.005706817843019962,0.8993407487869263,neutral,0.08924565464258194
56,2017-06-20 05:30:00,That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.,0.14883984625339508,0.00999003741890192,0.8411701321601868,neutral,0.13884980976581573
57,2017-06-20 05:30:00,"Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy.",0.3513948619365692,0.009931724518537521,0.6386734247207642,neutral,0.3414631485939026
58,2017-06-20 05:30:00,"Learn more about it here https://at.zacks.com/?id=112

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978.",0.016615888103842735,0.006967712193727493,0.9764164090156555,neutral,0.009648175910115242
59,2017-06-20 05:30:00,"The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin.",0.9116206169128418,0.04347905144095421,0.0449003241956234,positive,0.8681415915489197
60,2017-06-20 05:30:00,The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.,0.07881949096918106,0.006378026679158211,0.9148024916648865,neutral,0.072441466152668
61,2017-06-20 05:30:00,"In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!",0.43368902802467346,0.012674679979681969,0.5536363124847412,neutral,0.42101433873176575
62,2017-06-20 05:30:00,Click here for your free subscription to Profit from the Pros .,0.050681523978710175,0.02834671176970005,0.9209718108177185,neutral,0.022334812209010124
63,2017-06-20 05:30:00,"Get the full Report on ETSY - FREE

Get the full Report on LYV - FREE

Get the full Report on CRM - FREE

Get the full Report on VRTX - FREE

Get the full Report on NEO - FREE

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.012378966435790062,0.009596132673323154,0.978024959564209,neutral,0.0027828337624669075
64,2017-06-20 05:30:00,"Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions.",0.023836323991417885,0.005520980339497328,0.9706427454948425,neutral,0.01831534318625927
65,2017-06-20 05:30:00,"Zacks is providing information on this resource to you subject to the Zacks ""Terms and Conditions of Service"" disclaimer.",0.0142265185713768,0.008723904378712177,0.9770495891571045,neutral,0.005502614192664623
66,2017-06-20 05:30:00,www.zacks.com/disclaimer .,0.03363189846277237,0.05275096744298935,0.9136171340942383,neutral,-0.01911906898021698
67,2017-06-20 05:30:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
68,2017-06-20 05:30:00,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
69,2017-06-20 05:30:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
70,2017-06-20 05:30:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
71,2017-06-20 05:30:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
72,2017-06-20 05:30:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
73,2017-06-20 05:30:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
74,2017-06-20 05:30:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
75,2017-06-20 05:30:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
76,2017-06-20 05:30:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
77,2017-06-20 05:30:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
78,2017-06-20 05:30:00,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
79,2017-06-20 05:30:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
80,2017-06-20 05:30:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069374665617943,0.007019795011729002,0.9422864317893982,neutral,0.04367395117878914
81,2017-06-20 05:30:00,"Click to get this free report

To read this article on Zacks.com click here.",0.02068457007408142,0.033159855753183365,0.9461556077003479,neutral,-0.012475285679101944
82,2017-06-20 05:30:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
